Filing Flows › Alpha Teknova (TKNO) › Q3 2025
Alpha Teknova (TKNO) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 7, 2025
Alpha Teknova (TKNO) reported revenue of $10.5M for the third quarter 2025 (Q3 2025), +9% from a year earlier and +2% from the quarter before. Operating margin was -38.4%, net loss $4.3M (41.0% of revenue).
Alpha Teknova, Q3 2025: revenue $10.5M (+9% year over year), operating margin -38.4%, net loss $4.3M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.5M | +2% | +9% |
| Operating profit | −$4.0M | — | — |
| Net earnings | −$4.3M | — | — |
| Operating cash flow | −$2.0M | — | — |
What changed
Revenue was $10.5M in Q3 2025, up 9% year over year and up 2% from the previous quarter. Lab Essentials was the largest line at 79% of revenue. Lab Essentials added $1.1M year over year (up 16%), 131% of the total change. Clinical Solutions declined 13%.
Gross margin was 30.7%, up 29.7 points from a year earlier. Operating costs exceeded revenue by $4.0M, an operating margin of -38.4%. Operating expenses fell 4% while revenue rose 9%. The quarter ended with a net loss of $4.3M, wider than the previous quarter's $3.6M loss.
Operating cash flow was −$2.0M. Non-cash charges added back $1.6M of depreciation and amortization and $850K of share-based compensation. Working capital and other items used $135K. Capital expenditures of $387K exceeded it, leaving free cash flow of −$2.4M.
Questions
What was Alpha Teknova's revenue in the third quarter 2025?
Alpha Teknova (TKNO) reported revenue of $10.5M for the third quarter 2025 (Q3 2025), +9% from a year earlier and +2% from the quarter before.
Was Alpha Teknova profitable in the third quarter 2025?
Operating loss was $4.0M (-38.4% of revenue) and net loss $4.3M.
Source: Alpha Teknova 10-Q on SEC EDGAR.